Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective multicentre study focused on evaluating the incidence and risk factors for ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe asymptomatic aortic stenosis, the first in this patient population ...

For the first time in India, doctors at Rajasthan Hospital, Jaipur have successfully replaced a heart valve through the ...

The PROTECTED TAVR trial investigated the use of CEP to prevent stroke related to transcatheter aortic-valve replacement ... age of the participants was 81.2±6.5 years, and 38.7% were women.

Published last year in the New England Journal of Medicine and reported by TCTMD at that time, the study showed that treating patients who had severe aortic stenosis but no symptoms with TAVI halved ...